Clinical trial
Application of Mitoxantrone Hydrochloride Injection in Transoral Robotic Thyroid Cancer Surgery
NCT07354698 is registered in ClinicalTrials.gov with Daping Hospital and the Research Institute of Surgery of the Third Military Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Application of Mitoxantrone Hydrochloride Injection in Transoral Robotic Thyroid Cancer Surgery
- Lead sponsor
- Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
- Phase
- Phase 4
- Overall status
- Not yet recruiting
- Start date
- February 1, 2026
- Completion date
- February 1, 2028
- Enrollment
- 114 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
papillary thyroid cancer